Propylcathinone
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Propylcathinone (code name PAL-359), or N-propylcathinone, is a stimulant and designer drug of the amphetamine and cathinone families.[1][2][3] It is known to be inactive as a dopamine reuptake inhibitor and releasing agent.[3] Nonetheless, the drug substitutes for dextroamphetamine in animal drug discrimination tests.[1] The related agent propylamphetamine is known to be partially metabolized into amphetamine and this is thought to be involved in its effects.[4][5] Propylcathinone was first encountered as a novel designer drug in Europe by 2015.[6][7][2]
Other namesPC; PrC; 2-(Propylamino)propanophenone; α-Propylaminopropiophenone; PAP; N-Propylcathinone; β-Keto-N-propylamphetamine; N-Pr-CAT; PAL-359; PAL359
| Clinical data | |
|---|---|
| Other names | PC; PrC; 2-(Propylamino)propanophenone; α-Propylaminopropiophenone; PAP; N-Propylcathinone; β-Keto-N-propylamphetamine; N-Pr-CAT; PAL-359; PAL359 |
| Drug class | Stimulant; Monoamine releasing agent; Monoamine reuptake inhibitor |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C12H17NO |
| Molar mass | 191.274 g·mol−1 |
| 3D model (JSmol) | |
| |
| |